A comprehensive view of DaVita Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Davita Inc. Files SEC Form 8-K, Current Report: (Oct. 28, 2022)

DaVita reports Q3 net income down at US$105.5M from US$259.8M a year ago, total revenue US$2.95B from US$2.94B a year ago; results impacted by negative volume trends due to COVID-19 and continued labor pressure

DaVita reports Q2 net income down at US$224.8M from US$293.8M a year ago, with total revenue up at US$2.92B from US$2.91B a year ago; DaVita provided 7,269,160 dialysis treatment in Q2, up 0.9% from Q1 2022

US Supreme Court rejects DaVita’s claim that Ohio hospital's employee health plan discriminated against end-stage renal disease patients to switch them to Medicare; DaVita says ruling could result in private health plans limiting dialysis coverage

DaVita reports Q1 net income down at US$162.1M from US$237.4M a year ago, with consolidated revenue at US$2.8B, flat from a year ago; results impacted by COVID-19 volume pressures from excess patient mortality, higher missed treatments

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count